Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Yuriy Dudiy

Thoracic Surgery (Cardiothoracic Vascular Surgery) Hackensack, NJ Medical Doctor

NPI 1134416001 CMS profile 4224145

30 Prospect Ave, Hackensack, NJ 07601

Open in the dashboard

General payments

$36,722

347 records reported · program years 2019–2025

Research payments

$23

Paid to them · 1 record reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Research they led as principal investigator

$48,158 paid to institutions, not to them · program year 2024

Through program year 2025, Yuriy Dudiy of Hackensack, NJ is reported in the CMS Open Payments database as having received $36,722 across 347 general payments and $23 in research payments paid to them. Separately, studies naming them as principal investigator received $48,158 in research payments, paid to institutions rather than to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them. The principal-investigator line is research money paid to institutions for studies they led — not to them — and is not added to anything either.

General payments for this record sit in the 87th percentile of Thoracic Surgery (Cardiothoracic Vascular Surgery) profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

8 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $11,455 83
2024 General $4,846 94
2023 General $11,033 55
2022 General $3,268 57
2022 Research $23 1
2021 General $1,216 21
2020 General $2,266 10
2019 General $2,639 27

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Yuriy Dudiy
  • Thoracic Surgery (Cardiothoracic Vascular Surgery) median
  • Middle half of Thoracic Surgery (Cardiothoracic Vascular Surgery)
  • National median

In program year 2025, general payments to Yuriy Dudiy were reported at $11,455. Among 4,073 Thoracic Surgery (Cardiothoracic Vascular Surgery) profiles paid that year, the median was $791 and the middle half received between $208 and $3,074.

Show as a table
Year Yuriy Dudiy Thoracic Surgery (Cardiothoracic Vascular Surgery) median Middle half National median
2019 $2,639 $886 $178–$3,167 $163
2020 $2,266 $341 $108–$1,605 $114
2021 $1,216 $453 $125–$1,886 $132
2022 $3,268 $695 $180–$2,566 $149
2023 $11,033 $745 $205–$2,662 $160
2024 $4,846 $799 $214–$2,967 $164
2025 $11,455 $791 $208–$3,074 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Abiomed $21,172 109 payments
  2. Atricure, Inc. $3,276 37 payments
  3. Abbott Laboratories $3,087 52 payments
  4. Edwards Lifesciences Corporation $2,793 68 payments
  5. W. L. Gore & Associates, Inc. $2,030 21 payments
  6. Intuitive Surgical, Inc. $1,055 6 payments
  7. Medtronic Vascular, Inc. $1,037 13 payments
  8. Medtronic, Inc. $752 14 payments
  9. Stryker Corporation $300 1 payment
  10. Ancora Heart, Inc. $267 2 payments
  11. Other $953 24 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Food and Beverage $14,606 322 payments
  2. Consulting Fee $10,020 3 payments
  3. Honoraria $7,200 1 payment
  4. Travel and Lodging $4,896 21 payments
Products named General payments · program years 2019–2025
  1. Impella $11,781 75 payments
  2. Product in Development $1,744 12 payments
  3. EPI-SENSE GUIDED COAGULATION SYS $1,657 2 payments
  4. SAPIEN 3 Ultra RESILIA $1,347 43 payments
  5. Mitra Clip system $1,099 10 payments
  6. Da Vinci Surgical System $1,055 6 payments
  7. ATRICLIP LAA EXCLUSION SYSTEM $766 17 payments
  8. CoreValve Evolut $751 10 payments
  9. AMPLATZER Occluders $692 5 payments
  10. SYNERGY ABLATION SYSTEM $549 14 payments
  11. Other $6,276 137 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Research payments came from Research payments · program years 2019–2025
  1. Abiomed $23 1 payment

Billing to Medicare

Part B · data year 2024 · 44 billing codes

Paid by Medicare

$120,965

Medicare's payments for the services billed

Medicare patients

123

Average age 78

Services billed

206

44 women, 79 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Ischemic heart disease 75%
Arthritis 64%
Heart failure 63%
Diabetes 54%
Atrial fibrillation 49%
Chronic kidney disease 46%
COPD 34%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

348 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record